Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Diagnoplex SA and Unilabs Sign a Collaboration Agreement

Published: Thursday, September 19, 2013
Last Updated: Thursday, September 19, 2013
Bookmark and Share
Agreement to market the Colox® non-invasive colon cancer screening test.

Diagnoplex SA and Unilabs have signed a collaboration agreement to commercialize Colox®, a minimally invasive colorectal cancer assay within the Unilabs network.

The test will be available initially in the Swiss and Swedish markets.

The agreement combines Diagnoplex’s capacity to develop “high-return” molecular assays with Unilabs’ leading position in the European diagnostics market.

The agreement builds on a solid collaborative effort between the two companies and enables Unilabs to further differentiate itself through innovative molecular testing.

“This agreement opens a new and exciting chapter for Diagnoplex” said Stavros Therianos, founder and CEO of Diagnoplex SA. “We are able to enter into a strong collaboration with a European market leader such as Unilabs thanks to a patient- focused strategy for clinical product development. This collaboration demonstrates that a step-by-step approach, for the development of molecular screening tests, can effectively lead to the commercial availability of medically relevant diagnostics”.

Fernando de Górgolas, Unilabs Group Marketing & Business Development Director, said, “This collaboration with Diagnoplex is consistent with our strategy of launching innovative tests, that can bring a real benefit to patients and the healthcare community. Colox will strengthen the role of our molecular genetics laboratories in the diagnosis and monitoring of colorectal cancer.”

Thierry Mauvernay, Delegate of the Board of Debiopharm Group - a lead investor in Diagnoplex - agreed, adding “We are delighted that Diagnoplex has been able to establish this collaboration with an important actor in diagnostic market. We believe the Colox blood test has the potential to greatly increase the percentage of people that will be correctly screened for colorectal cancer”.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Blood Pressure Drug May Boost Effectiveness of Lung Cancer Treatment
Researchers at Imperial College London have suggested that the blood pressure drug may make a type of lung cancer treatment more effective.
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
New Discovery May Benefit Farmers Worldwide
Scientists have shown how a crop-microbe 'team' protect against fungal infection.
Antibodies Paving the Way to HIV Vaccine
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Protein Studies Discover Molecular Secrets
Two protein studies have mapped proteins that reveal the secrets to recycling carbon and healing cells.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!